Status:
COMPLETED
Immunopathogenesis of Chlamydia
Lead Sponsor:
Arkansas Children's Hospital Research Institute
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
CHLAMYDIA INFECTIONS
Eligibility:
FEMALE
11-21 years
Brief Summary
Sexually transmitted Chlamydia trachomatis infections are a widespread public health concern due to their prevalence and potentially devastating reproductive consequences, including pelvic inflammator...
Detailed Description
Sexually transmitted Chlamydia trachomatis infections are a widespread public health concern due to their prevalence and potentially devastating reproductive consequences, including pelvic inflammator...
Eligibility Criteria
Inclusion
- Female
- 11 to 21 years of age at the time of enrollment
- Positive for Chlamydia infections by urine or cervical PCR
- 5th Chlamydia-negative subject who fits all other inclusion criteria
- Negative pregnancy test
- Written informed consent provided
- Signed a HIPAA authorization form
- Willingness to comply with all the requirements of the protocol
Exclusion
- Positive pregnancy test
- Negative for Chlamydia, unless 5th negative subject to be in the control group
- Any condition that in the opinion of the investigator would interfere with the ability of the potential subject to complete the study or would result in significant risk to the subject
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT00607659
Start Date
January 1 2008
End Date
January 1 2016
Last Update
April 14 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arkansas Children's Hospital
Little Rock, Arkansas, United States, 72202